^
CANCER:

Myelodysplastic Syndrome

No biomarker
MDS
TP53 mutation
MDS
ASXL1 mutation
MDS
ASXL1 deletion
MDS
No biomarker
MDS
No biomarker
MDS
Chr del(5q)
MDS
No biomarker
MDS
No biomarker
MDS
PDGFRA rearrangement
MDS
CALR mutation
MDS
CALR mutation
MDS
MPL W515L
MDS
MPL W515L
MDS
JAK2 V617F
MDS
SF3B1 mutation
MDS
JAK2 V617F
MDS
SF3B1 mutation
MDS
No biomarker
MDS
DNMT3A mutation + SF3B1 mutation
MDS
No biomarker
MDS
No biomarker
MDS
Chr del(5)(q31)
MDS
No biomarker
MDS
TP53 mutation
MDS
FLT3 mutation
MDS
TP53 mutation
MDS
TET2 mutation
MDS
TP53 mutation
MDS
RUNX1 mutation
MDS
ASXL1 mutation
MDS
IDH2 mutation
MDS
MECOM mutation + KDM6B mutation
MDS
MECOM mutation + KDM6A mutation
MDS
RUNX1 mutation
MDS
DNMT3A mutation
MDS
ASXL1 mutation
MDS
TET2 mutation
MDS
BNIP3L elevation
MDS
LDHA elevation
MDS
HIF1A overexpression
MDS
TP53 mutation
MDS
PIK3CD mutation
MDS
PLCG2 mutation
MDS
AKT3 mutation
MDS
TMB-H
MDS
SF3B1 K700E
MDS
SF3B1 mutation + Chr del(5q)
MDS
Chr del(20q) + ASXL1 mutation
MDS
Chr del(20q) + ASXL1 deletion
MDS
DNMT3A mutation
MDS
DNMT3A mutation
MDS
TP53 mutation
MDS
U2AF1 mutation
MDS
U2AF1 mutation
MDS
NPM1 mutation
MDS
RRM1 underexpression
MDS
Chr del(5q) + TP53 expression
MDS
Chr del(5)(q31.1)
MDS
EZH2 mutation
MDS
SLFN11 expression
MDS
ANG elevation
MDS
AXL elevation
MDS
JDP2 overexpression
MDS
SPI1 overexpression
MDS
Chr del(17p)
MDS
NPM1 mutation
MDS
SETBP1 mutation
MDS
RUNX1 mutation
MDS
IDH1 mutation
MDS
TP53 mutation
MDS
TP53 mutation
MDS
BCR-ABL1 fusion
MDS
PCM1-PDGFRB fusion
MDS
PAN3-PSMA2 fusion
MDS
MCL1 expression
MDS